688617 惠泰医疗
已收盘 05-22 15:00:02
资讯
新帖
简况
顶流基金经理最新动向出炉：张坤减持惠泰医疗，朱少醒、谢治宇调研这些股
澎湃新闻 · 05-20
顶流基金经理最新动向出炉：张坤减持惠泰医疗，朱少醒、谢治宇调研这些股
每周股票复盘：惠泰医疗（688617）董事长增持1.0万股并完成计划
证券之星 · 05-17
每周股票复盘：惠泰医疗（688617）董事长增持1.0万股并完成计划
惠泰医疗：5月14日董事长赵宇翔增持股份合计10000股
证券之星 · 05-14
惠泰医疗：5月14日董事长赵宇翔增持股份合计10000股
惠泰医疗（688617）披露以集中竞价交易方式回购股份的回购报告书，5月13日股价上涨2.71%
证券之星 · 05-13
惠泰医疗（688617）披露以集中竞价交易方式回购股份的回购报告书，5月13日股价上涨2.71%
每周股票复盘：惠泰医疗（688617）每股派现1元，股权登记日为5月13日
证券之星 · 05-10
每周股票复盘：惠泰医疗（688617）每股派现1元，股权登记日为5月13日
惠泰医疗（688617）披露2025年年度权益分派实施公告，5月7日股价上涨0.09%
证券之星 · 05-07
惠泰医疗（688617）披露2025年年度权益分派实施公告，5月7日股价上涨0.09%
每周股票复盘：惠泰医疗（688617）管理层调整聚焦营销赋能与研发协同
证券之星 · 05-02
每周股票复盘：惠泰医疗（688617）管理层调整聚焦营销赋能与研发协同
【机构调研记录】国投瑞银基金调研惠泰医疗、兔 宝 宝
证券之星 · 04-30
【机构调研记录】国投瑞银基金调研惠泰医疗、兔 宝 宝
股市必读：惠泰医疗（688617）4月29日披露最新机构调研信息
证券之星 · 04-30
股市必读：惠泰医疗（688617）4月29日披露最新机构调研信息
股市必读：惠泰医疗一季报 - 第一季度单季净利润同比增长25.27%
证券之星 · 04-27
股市必读：惠泰医疗一季报 - 第一季度单季净利润同比增长25.27%
惠泰医疗(688617)3月31日股东户数0.65万户，较上期增加8.21%
证券之星 · 04-24
惠泰医疗(688617)3月31日股东户数0.65万户，较上期增加8.21%
惠泰医疗最新公告：第一季度净利润同比增长25.27%
证券之星 · 04-23
惠泰医疗最新公告：第一季度净利润同比增长25.27%
惠泰医疗：4月15日接受机构调研，淡马锡(上海)股权投资基金管理有限公司、招商基金管理有限公司等多家机构参与
证券之星 · 04-21
惠泰医疗：4月15日接受机构调研，淡马锡(上海)股权投资基金管理有限公司、招商基金管理有限公司等多家机构参与
每周股票复盘：惠泰医疗（688617）授出178万股限制性股票
证券之星 · 04-19
每周股票复盘：惠泰医疗（688617）授出178万股限制性股票
惠泰医疗（688617）披露关于调整2025年度利润分配现金分红总额的公告，4月16日股价下跌0.5%
证券之星 · 04-16
惠泰医疗（688617）披露关于调整2025年度利润分配现金分红总额的公告，4月16日股价下跌0.5%
惠泰医疗（688617）披露2026年限制性股票激励计划首次授予公告，4月15日股价上涨0.58%
证券之星 · 04-15
惠泰医疗（688617）披露2026年限制性股票激励计划首次授予公告，4月15日股价上涨0.58%
每周股票复盘：惠泰医疗（688617）2026年PF手术量将快速增长
证券之星 · 04-12
每周股票复盘：惠泰医疗（688617）2026年PF手术量将快速增长
股市必读：惠泰医疗（688617）4月8日披露最新机构调研信息
证券之星 · 04-09
股市必读：惠泰医疗（688617）4月8日披露最新机构调研信息
惠泰医疗：公司预计2026年PFA手术量有较快的增长速度
证券日报 · 04-08
惠泰医疗：公司预计2026年PFA手术量有较快的增长速度
惠泰医疗（688617）披露2025年年度股东会会议资料，4月7日股价上涨0.56%
证券之星 · 04-07
惠泰医疗（688617）披露2025年年度股东会会议资料，4月7日股价上涨0.56%
加载更多
公司概况
公司名称：
深圳惠泰医疗器械股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-01-07
主营业务：
深圳惠泰医疗器械股份有限公司的主营业务是心血管介入医疗器械的研发、生产和销售。公司的主要产品是电生理、冠脉通路、外周血管介入、非血管介入医疗器械。
发行价格：
74.46
{"stockData":{"symbol":"688617","market":"SH","secType":"STK","nameCN":"惠泰医疗","latestPrice":217.2,"timestamp":1779433202000,"preClose":221.93,"halted":0,"volume":1402861,"delay":0,"changeRate":-0.0213,"floatShares":141000000,"shares":141000000,"eps":6.1466,"marketStatus":"已收盘","change":-4.73,"latestTime":"05-22 15:00:02","open":226,"high":226,"low":215.52,"amount":306000000,"amplitude":0.0472,"askPrice":217.86,"askSize":5,"bidPrice":217.2,"bidSize":16,"shortable":0,"etf":0,"ttmEps":6.1466,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779672600000},"marketStatusCode":5,"adr":0,"adjPreClose":221.93,"symbolType":"stock_kcb","openAndCloseTimeList":[[1779413400000,1779420600000],[1779426000000,1779433200000]],"highLimit":244.12,"lowLimit":199.74,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":141041779,"isCdr":false,"pbRate":10.32,"roa":"--","peRate":35.336609,"roe":"7.54%","epsLYR":5.82,"committee":0.208333,"marketValue":30634000000,"turnoverRate":0.0099,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-05-26。","afterMarket":{"amount":0,"volume":0,"close":217.2,"buyVolume":0,"sellVolume":0,"time":1779435237558,"indexStatus":"已收盘 05-22 15:30:00","preClose":221.93},"floatMarketCap":30634000000},"requestUrl":"/m/hq/s/688617/","defaultTab":"news","newsList":[{"id":"2636898218","title":"顶流基金经理最新动向出炉：张坤减持惠泰医疗，朱少醒、谢治宇调研这些股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636898218","media":"澎湃新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636898218?lang=zh_cn&edition=full","pubTime":"2026-05-20 07:24","pubTimestamp":1779233040,"startTime":"0","endTime":"0","summary":"多位知名基金经理最新调仓路径与调研动向出炉。具体来看，易方达张坤管理的易方达蓝筹精选，在二季度期间小幅减持高新技术企业惠泰医疗，而对五粮液（维权）的持仓则按兵不动；工银瑞信杨鑫鑫管理的工银创新动力，也对手中的重仓股玲珑轮胎进行了微调。值得一提的是，朱少醒、谢治宇、乔迁、史博等多位百亿基金经理也频频现身调研名单，释放布局信号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-05-20/doc-inhynvwt1812081.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-05-20/doc-inhynvwt1812081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636629061","title":"每周股票复盘：惠泰医疗（688617）董事长增持1.0万股并完成计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2636629061","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636629061?lang=zh_cn&edition=full","pubTime":"2026-05-17 02:00","pubTimestamp":1778954432,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，惠泰医疗报收于234.21元，较上周的232.61元上涨0.69%。本周，惠泰医疗5月13日盘中最高价报242.79元。来自公司公告汇总：调整2021年限制性股票激励计划授予价格，并确认第二期归属条件符合。股本股东变化高管增减持2026年5月14日，惠泰医疗董事长赵宇翔增持公司股份1.0万股，占总股本0.0071%。回购股份将用于员工持股计划或股权激励；若三年内未转让完毕，未转让股份将依法注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635743248","title":"惠泰医疗：5月14日董事长赵宇翔增持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635743248","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635743248?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:01","pubTimestamp":1778767292,"startTime":"0","endTime":"0","summary":"证券之星消息，根据5月14日市场公开信息、上市公司公告及交易所披露数据整理，惠泰医疗最新董监高及相关人员股份变动情况：2026年5月14日公司董事长赵宇翔共增持公司股份1.0万股，占公司总股本为0.0071%。惠泰医疗近半年内的董监高及核心技术人员增减持详情如下：惠泰医疗的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入984.96万，融资余额增加；融券净流出797.0，融券余额减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400042620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635200676","title":"惠泰医疗（688617）披露以集中竞价交易方式回购股份的回购报告书，5月13日股价上涨2.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635200676","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635200676?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:50","pubTimestamp":1778665804,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，惠泰医疗报收于241.98元，较前一交易日上涨2.71%，最新总市值为341.29亿元。公司于2026年5月13日披露《关于以集中竞价交易方式回购股份的回购报告书》。公告显示，深圳惠泰医疗器械股份有限公司计划以集中竞价交易方式回购股份，回购资金总额不低于5000万元且不超过10000万元，资金来源为自有资金。相关股东在回购决议日前后无明确减持计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300033033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634411037","title":"每周股票复盘：惠泰医疗（688617）每股派现1元，股权登记日为5月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2634411037","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634411037?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:01","pubTimestamp":1778349671,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，惠泰医疗报收于232.61元，较上周的237.87元下跌2.21%。本周，惠泰医疗5月6日盘中最高价报237.92元。本周关注点公司公告汇总：惠泰医疗2025年年度权益分派实施，每股现金红利1元（含税），股权登记日为2026年5月13日。截至申请日，公司总股本为141,041,779股，回购专户持有1,869,440股，实际参与分配股份数为139,172,339股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633126419","title":"惠泰医疗（688617）披露2025年年度权益分派实施公告，5月7日股价上涨0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633126419","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633126419?lang=zh_cn&edition=full","pubTime":"2026-05-07 22:53","pubTimestamp":1778165592,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，惠泰医疗报收于234.6元，较前一交易日上涨0.09%，最新总市值为330.88亿元。该股当日开盘235.77元，最高235.77元，最低230.61元，成交额达1.91亿元，换手率为0.58%。近日，惠泰医疗发布《2025年年度权益分派实施公告》。股权登记日为2026年5月13日，除权（息）日和现金红利发放日均为2026年5月14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700041680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632764734","title":"每周股票复盘：惠泰医疗（688617）管理层调整聚焦营销赋能与研发协同","url":"https://stock-news.laohu8.com/highlight/detail?id=2632764734","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632764734?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:13","pubTimestamp":1777666388,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，惠泰医疗报收于237.87元，较上周的248.0元下跌4.08%。本周，惠泰医疗4月28日盘中最高价报251.74元。答：本次管理层的调整，属于迈瑞对惠泰进行整合协同过程中的正常人员调整；公司2024年4月正式并入迈瑞集团，在过去两年，整合协同的重点聚焦于研发领域，尤其是电生理的研发。为了更好适配公司现阶段业务发展的需要，公司进行了本次管理层调整。本次人员调整，是迈瑞与公司核心管理层充分商议、达成高度一致的结果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631575246","title":"【机构调研记录】国投瑞银基金调研惠泰医疗、兔 宝 宝","url":"https://stock-news.laohu8.com/highlight/detail?id=2631575246","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631575246?lang=zh_cn&edition=full","pubTime":"2026-04-30 08:05","pubTimestamp":1777507557,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月29日披露的机构调研信息，国投瑞银基金近期对2家上市公司进行了调研，相关名单如下：1）惠泰医疗 调研纪要：公司2024年4月正式并入迈瑞集团，整合重点聚焦研发，尤其电生理领域，已与迈瑞实现深度融合，成立BMC，2026年起迈瑞研发骨干正式加入。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000028092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631257521","title":"股市必读：惠泰医疗（688617）4月29日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2631257521","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631257521?lang=zh_cn&edition=full","pubTime":"2026-04-30 04:50","pubTimestamp":1777495813,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，惠泰医疗报收于242.76元，下跌0.14%，换手率0.52%，成交量7393.0手，成交额1.8亿元。当日关注点来自交易信息汇总：4月29日主力资金净流出597.6万元，游资资金净流入739.26万元。来自机构调研要点：新任董事长赵宇翔全职加入惠泰，体现迈瑞对营销赋能的更高要求。机构调研要点本次管理层调整是迈瑞整合惠泰过程中正常的人事安排，聚焦研发协同后转向营销赋能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000015305.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630533701","title":"股市必读：惠泰医疗一季报 - 第一季度单季净利润同比增长25.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630533701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630533701?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:54","pubTimestamp":1777251251,"startTime":"0","endTime":"0","summary":"来自股本股东变化：截至2026年3月31日，惠泰医疗股东户数为6525.0户，较2月28日增加8.21%。来自业绩披露要点：惠泰医疗2026年一季度主营收入7.04亿元，同比增长24.78%；归母净利润2.29亿元，同比增长25.27%。业绩披露要点财务报告惠泰医疗2026年一季报显示，一季度公司主营收入7.04亿元，同比上升24.78%；归母净利润2.29亿元，同比上升25.27%；扣非净利润2.25亿元，同比上升24.72%；负债率12.34%，投资收益966.4万元，财务费用470.55万元，毛利率72.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700007790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629149748","title":"惠泰医疗(688617)3月31日股东户数0.65万户，较上期增加8.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629149748","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629149748?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:31","pubTimestamp":1777023106,"startTime":"0","endTime":"0","summary":"证券之星消息，近日惠泰医疗披露，截至2026年3月31日公司股东户数为6525.0户，较2月28日增加495.0户，增幅为8.21%。在医疗器械行业个股中，惠泰医疗股东户数低于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.18万户。从股价来看，2026年2月28日至2026年3月31日，惠泰医疗区间涨幅为1.52%，在此期间股东户数增加495.0户，增幅为8.21%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400052663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629834590","title":"惠泰医疗最新公告：第一季度净利润同比增长25.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629834590","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629834590?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:41","pubTimestamp":1776948068,"startTime":"0","endTime":"0","summary":"惠泰医疗(688617.SH)公告称，2026年第一季度实现营业收入7.04亿元，同比增长24.78%；归属于上市公司股东的净利润为2.29亿元，同比增长25.27%。注：公司Q1净利润2.29亿，2025年Q4净利润1.97亿，据此计算，Q1净利润环比增长16%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300058680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629033803","title":"惠泰医疗：4月15日接受机构调研，淡马锡(上海)股权投资基金管理有限公司、招商基金管理有限公司等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2629033803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629033803?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:49","pubTimestamp":1776768557,"startTime":"0","endTime":"0","summary":"未来血管介入产品的营收份额将逐步提升。公司手术跟台工程师的跟台奖金，优于同行业水平，薪酬结构以绩效奖金为主、固定薪酬为辅。公司已着手调整固浮比。该股最近90天内共有10家机构给出评级，买入评级7家，增持评级3家；过去90天内机构目标均价为328.84。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100044479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628759539","title":"每周股票复盘：惠泰医疗（688617）授出178万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2628759539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628759539?lang=zh_cn&edition=full","pubTime":"2026-04-19 02:31","pubTimestamp":1776537066,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，惠泰医疗报收于256.02元，较上周的260.47元下跌1.71%。公司公告汇总深圳惠泰医疗器械股份有限公司董事会薪酬与考核委员会确认，2026年限制性股票激励计划首次授予激励对象共663人，符合任职资格和激励条件，不包括独立董事及持股5%以上股东及其亲属。同意以240.00元/股的价格向其授予1,780,501股限制性股票，首次授予日为2026年4月14日。首次授予激励对象名单显示，663名激励对象合计获授1,780,501股，占公司股本总额的1.262%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627950092","title":"惠泰医疗（688617）披露关于调整2025年度利润分配现金分红总额的公告，4月16日股价下跌0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627950092","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627950092?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:27","pubTimestamp":1776331670,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘，惠泰医疗报收于257.21元，较前一交易日下跌0.5%，最新总市值为362.77亿元。公司于2026年4月16日发布《关于调整2025年度利润分配现金分红总额的公告》。分配基数为股权登记日总股本扣除回购专户股份数，不进行资本公积转增股本，不送红股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600031611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627076914","title":"惠泰医疗（688617）披露2026年限制性股票激励计划首次授予公告，4月15日股价上涨0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627076914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627076914?lang=zh_cn&edition=full","pubTime":"2026-04-15 17:06","pubTimestamp":1776244019,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘，惠泰医疗报收于258.5元，较前一交易日上涨0.58%，最新总市值为364.59亿元。公司于近日披露《关于向2026年限制性股票激励计划激励对象首次授予限制性股票的公告》。公告显示，深圳惠泰医疗器械股份有限公司于2026年4月14日确定向663名激励对象首次授予1,780,501股限制性股票，授予价格为240.00元/股，股票来源为二级市场回购或定向发行。北京市嘉源律师事务所出具法律意见书，认为本次授予符合相关法律法规及《激励计划》规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500030472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626147124","title":"每周股票复盘：惠泰医疗（688617）2026年PF手术量将快速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2626147124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626147124?lang=zh_cn&edition=full","pubTime":"2026-04-12 01:13","pubTimestamp":1775927587,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘，惠泰医疗报收于260.47元，较上周的255.86元上涨1.8%。本周，惠泰医疗4月9日盘中最高价报264.7元。惠泰医疗当前最新总市值367.37亿元，在医疗器械板块市值排名5/129，在两市A股市值排名563/5196。基于公司业务推进与行业发展状况，公司预计2026年PF手术量有较快的增长速度。公司IBP产品目前处于注册发补阶段，该产品将作为公司心血管介入产品线的重要补充，可进一步完善整体布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626926306","title":"股市必读：惠泰医疗（688617）4月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2626926306","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626926306?lang=zh_cn&edition=full","pubTime":"2026-04-09 01:04","pubTimestamp":1775667856,"startTime":"0","endTime":"0","summary":"截至2026年4月8日收盘，惠泰医疗报收于264.5元，上涨2.81%，换手率0.85%，成交量1.2万手，成交额3.13亿元。当日关注点来自交易信息汇总：4月8日主力资金净流出1059.32万元，游资资金净流入1250.73万元。来自机构调研要点：电生理业务海外布局以欧洲为重点，同步拓展东欧、拉美、亚太及中东市场。来自机构调研要点：公司IBP产品目前处于注册发补阶段，将成为心血管介入产品线的重要补充。公司预计2026年PF手术量将实现较快增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900000971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625944595","title":"惠泰医疗：公司预计2026年PFA手术量有较快的增长速度","url":"https://stock-news.laohu8.com/highlight/detail?id=2625944595","media":"证券日报 ","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625944595?lang=zh_cn&edition=full","pubTime":"2026-04-08 20:22","pubTimestamp":1775650920,"startTime":"0","endTime":"0","summary":"证券日报网4月8日讯 ，惠泰医疗在接受调研者提问时表示，基于公司业务推进与行业发展状况，公司预计2026年PFA手术量有较快的增长速度。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-04-08/doc-inhtuyvv6410178.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-04-08/doc-inhtuyvv6410178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625936167","title":"惠泰医疗（688617）披露2025年年度股东会会议资料，4月7日股价上涨0.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625936167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625936167?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:15","pubTimestamp":1775553332,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，惠泰医疗报收于257.28元，较前一交易日上涨0.56%，最新总市值为362.84亿元。该股当日开盘256.51元，最高258.28元，最低252.7元，成交额达2.29亿元，换手率为0.64%。公司于近日披露《2025年年度股东会会议资料》。公告显示，深圳惠泰医疗器械股份有限公司2025年度实现营业收入258,392.73万元，同比增长25.08%；归属于母公司股东的净利润82,063.66万元，同比增长21.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779524331331,"stockEarnings":[{"period":"1week","weight":-0.0726},{"period":"1month","weight":-0.1336},{"period":"3month","weight":-0.0617},{"period":"6month","weight":-0.158},{"period":"1year","weight":-0.2354},{"period":"ytd","weight":-0.1035}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0076},{"period":"6month","weight":0.0725},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳惠泰医疗器械股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"6525人(较上一季度增加8.21%)","perCapita":"21615股","listingDate":"2021-01-07","address":"广东省深圳市南山区西丽街道松坪山社区松坪山朗山路11号同方信息港B栋601","registeredCapital":"14104万元","survey":" 深圳惠泰医疗器械股份有限公司的主营业务是心血管介入医疗器械的研发、生产和销售。公司的主要产品是电生理、冠脉通路、外周血管介入、非血管介入医疗器械。","listedPrice":74.46},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"惠泰医疗(688617)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供惠泰医疗(688617)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"惠泰医疗,688617,惠泰医疗股票,惠泰医疗股票老虎,惠泰医疗股票老虎国际,惠泰医疗行情,惠泰医疗股票行情,惠泰医疗股价,惠泰医疗股市,惠泰医疗股票价格,惠泰医疗股票交易,惠泰医疗股票购买,惠泰医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"惠泰医疗(688617)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供惠泰医疗(688617)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}